• Users Online: 338
  • Home
  • Print this page
  • Email this page
Home About us Editorial board Search Ahead of print Current issue Archives Submit article Instructions Subscribe Contacts Login 
Year : 2022  |  Volume : 9  |  Issue : 4  |  Page : 279-281

Complexities of Covishield Vaccine on COVID-Positive History Family in India after the Second (Booster) Dose

1 Department of Electrical Engineering, PVGs College of Engineering and Technology, Pune, Maharashtra, India
2 Department of Physics, Nowrosjee Wadia College, Pune, Maharashtra, India

Correspondence Address:
Parikshit Gautam Jamdade
PVGs College of Engineering and Technology, Pune, Maharashtra
Login to access the Email id

Source of Support: None, Conflict of Interest: None

DOI: 10.4103/cjhr.cjhr_50_22

Rights and Permissions

COVID-19 epidemic severely affects the social life of people living in India. The best solution to the COVID-19 problem is the vaccination of the people. In India, COVID-19 vaccination started from January 16, 2021, mainly with the Covishield vaccine. In this study, the COVID-positive history family was selected who had taken the first and second (booster) doses residing at Pune, Maharashtra, India, was followed up to check for any side effects postvaccination. Their data were collected with participant-administered questions. The predominant side effects reported were uneasiness, pyrexia (fever), voice difference, vomiting, and headache. The side effects were started at 2–16 h postvaccination while it takes an average duration of 48–60 h to last. Analysis shows nonpresence of major and serious side effects makes the Covidshield vaccine safe for use in the COVID-positive history population.

Print this article     Email this article
 Next article
 Previous article
 Table of Contents

 Similar in PUBMED
   Search Pubmed for
   Search in Google Scholar for
 Related articles
 Citation Manager
 Access Statistics
 Reader Comments
 Email Alert *
 Add to My List *
 * Requires registration (Free)

 Article Access Statistics
    PDF Downloaded18    
    Comments [Add]    

Recommend this journal